Built.’s Post

Webinar > Navigating the Regulatory Landscape for Innovative Biomedical Applications > NXTGEN Hightech Biomedical and High Tech NL and  invite you to join us for an insightful webinar on September 4, 2024, from 16:00 to 17:00 CET. This engaging and practical webinar will feature hands-on advice drawn from the extensive experience of Qserve Group, a leading consultancy in #regulatory affairs. Attendees will gain valuable insights into: - The importance of early regulatory involvement - Essential milestones necessary for preparing the launch of your biomedical innovations Registration > https://lnkd.in/eFcz7cqe More information > https://lnkd.in/eCEUdy87 NXTGEN Hightech #lifescience, #biomedical, #innovation, #healthcare, #biotechnology, #engineering, #biosensing, #organonchip, #labonchip, #cellproduction #artificialorgans

Interesting webinar to become aware of the importance of early regulatory involvement in the development of innovative biomedical products! An initiative from NXTGEN Hightech Biomedical Production Technologies and High Tech NL.

𝗦𝗼𝗹𝘂𝗯𝗶𝗹𝗶𝘁𝘆 𝗠𝗲𝗮𝘀𝘂𝗿𝗲𝗺𝗲𝗻𝘁 𝗼𝗻 𝘁𝗵𝗲 𝗠𝗼𝘃𝗲! Berlin, 22 July 2024: 𝘼 𝙀𝙐𝙍𝙊𝙋𝙀𝘼𝙉 𝘾𝙊𝙉𝙎𝙊𝙍𝙏𝙄𝙐𝙈 𝙍𝙀𝘾𝙀𝙄𝙑𝙀𝙎 𝘼 2.5 𝙈 € 𝙂𝙍𝘼𝙉𝙏 𝙏𝙊 𝙎𝙐𝙋𝙋𝙊𝙍𝙏 𝘼 𝙎𝙐𝙎𝙏𝘼𝙄𝙉𝘼𝘽𝙇𝙀 𝙏𝙀𝘾𝙃𝙉𝙊𝙇𝙊𝙂𝙔 𝙏𝙊 𝙈𝙀𝘼𝙎𝙐𝙍𝙀 𝙏𝙃𝙀 𝙎𝙊𝙇𝙐𝘽𝙄𝙇𝙄𝙏𝙔 𝙊𝙁 𝘿𝙍𝙐𝙂𝙎 FASS, a consortium of Swiss, German and French partners, announces that it was awarded the prestigious EIC Transition grant amounting € 2.5 M. FASS stands for ‘Fast and Accurate Solubility for Sustainability’ with the aim to bring to the market a revolutionary laboratory instrument for the measurement of the solubility of drug molecules. The consortium is led by EU-OPENSCREEN ERIC, the European research infrastructure for early drug discovery and chemical biology with its central office in Germany. Other consortium members are Oryl Photonics, a Swiss spin-off from EPFL; Fachhochschule Nordwestschweiz (University of Applied Sciences and Arts Northwestern Switzerland FHNW) based in Switzerland; and ALPhANOV, a research and technology organization based in France. “We are very happy to receive this grant, a proof of the excellence of the project and the competence of the consortium. This emphasizes the unmet need of the market for the new solution we are proposing, both in terms of research improvement and environmental breakthrough” shares Robert Harmel, Scientific project manager at EU-OPENSCREEN. “This grant will accelerate the development and market entry of our laboratory instrument. Oryl Photonics is excited to make a world impact through its light-scattering based technology that fills a gap in the market offering of solubility measurement. The output of the grant will empower researchers in the pharmaceutical, chemical and life sciences industries to achieve more in their work, with sustainability and performance in mind.” shares Orly Tarun, CEO & Co-founder of Oryl Photonics. #solubility #pharmaceuticals

When looking for an absorbable, biocompatible material for their minimally invasive implant to treat nasal septal deviation, Stanford Byers Center for Biodesign innovation fellows James Kintzing and Dr. Brandon M. (McCutcheon) considered several polymers before selecting polydioxanone. In our latest Medical Design & Outsourcing contribution, the Spirair founders discussed why they picked PDO and what they learned in the process: https://lnkd.in/gubxQqN7

Workshop about Commercialization of Microfluidics Devices and Systems, provided by Scope Fluidics, will be a part of the 27th International Conference on Miniaturized Systems for Chemistry and Life Sciences (µTAS 2023). The conference will be held at the ICC International Congress Centre Katowice, in Katowice, Poland from 15-19 October 2023. The workshop organized by Scope Fluidics will by leading by prof. Piotr Garstecki (Scope Fluidics CEO) with attendance of Vincent Lindner, BioMedical Entrepreneur and IVD Independent Consultant and also Tomasz Kosiński, Director Discovery and Growth Projects, and Marcin Myszkowski, Head of Clinical Trials and Regulatory Affairs from Scope Fluidics. As the Scope Fluidics team announce: We will discuss the (i) discovery and identification of key features of the invention; (ii) conceptualization of the product or service; (iii) gauging the value; (iv) assessing the competitive edge; (v) protecting and navigating the intellectual property; (vi) regulatory aspects of access to the market; (vii) manufacturability at acceptable cost; (viii) business model and requirements for development stemming from the way of use; (ix) quality management system; (x) key phases of product development; (xi) early access & market entry; (xii) team building. We expect to have the session highly interactive with ample room for Q&A and discussion of select examples and specific challenges pointed out by the participants. See you in Katowice! #ScopeFluidics #MicroTAS #microfluidics #moleculardiagnostics

The Institute for Biomedical and Biosciences Research (IBBR) welcomes partnerships and industrial collaborations to bring you complementary skills and help you to optimise your preclinical drug candidates’ studies. Watch our new video

⭐ ODIN visited #SDU today ⭐ Programme leader Marie Louise Conradsen presented Open Discovery Innovation Network (ODIN) today ahead of the Kick Off on the 27th of May – see link below. ODIN is a collaboration platform where industry and academia co-create open research projects relevant for drug discovery and diagnostics. ODIN is a 5-year collaboration platform from 2024-2028 sponsored by the Novo Nordisk Foundation with up to 180 M DKK. See more about funding opportunities below: https://lnkd.in/dV4DTmyJ Through ODIN, a collaborative arena is offered where universities, hospitals, and industry can work together and develop new solution platforms without any IPR being involved. Pre-competitive collaboration entails partnerships between companies, universities, research centres, and patient associations that collaborate with the aim of facilitating the translation process between basic research and application by exchanging knowledge, data, technologies, and resources with each other in a patent-free playground. This approach can certainly be of interest in relation to the new research strategy for #SDU_SUND, which we look forward to launching soon. Uffe Holmskov Jakob Møller-Jensen Carolin Müller Lone Ladegaard Laursen Simone Rørdam-Preil Sidse Faxøe Enghave Marlene Pedersen Elnegaard Jens Troelsen Bjarne Dahler-Eriksen

🔬 B-Series Equipment -78 : Bacterial Culture Plate. Today, we’re highlighting the B-Series Equipment -78, an essential tool for bacterial culture plate management. This equipment is engineered to provide precise temperature control, crucial for maintaining the optimal conditions needed for accurate bacterial growth and culture. #MedicalEquipment #BSeriesEquipment #BacterialCulture #LaboratoryTech #ScientificResearch #PrecisionInScience #DailyUpdate #LabInnovation #MedicalResearch #EquipmentSpotlight

B Series Equipment -83 :Blood Pressure Cuff. A blood pressure cuff is a vital instrument in healthcare used to measure blood pressure, a key indicator of cardiovascular health. #Healthcare #MedicalEquipment #BloodPressureMonitoring #PatientCare #MedicalTechnology #HealthcareInnovation #ClinicalTools #BSeries #HealthTech

Early bird rates end June 3 for BioCentury Grand Rounds – an R&D conference in Nashville for academic innovators, researchers, investors and industry leaders to explore the translational science behind the next wave of biotech breakthroughs and the people driving them. Take advantage of these special rates and make connections with peers across the biopharma sphere as we discuss: ➤ What Investors Want: Gain insights from top investors on what they’re looking for in today’s market.   ➤ New Investible Space: Discover emerging sectors and opportunities that are catching the eye of investors.   ➤ Measurements of Translational Success: Learn how to measure and showcase the impact of your innovations. Register now to secure your spot at #BioCenturyGrandRounds: https://loom.ly/yydzbC8 Submit your nominations to join the Presenting Companies Class of 2024 by June 3 to lock in early bird rates: https://loom.ly/GHHuDog #GrandRounds #BiotechBreakthroughs #researchdevelopment #academia #venturecapital #biotech #drugdiscovery #drugdevelopment #RnD